Profile
TAK ZTS HLN TEVA ITCI NBIX
Company Name Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc. Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $45.57B $67.47B $44.51B $18.42B $14.05B $13.27B
Employees 49.28K 13.80K 24.56K 37.00K 0.86K 1.80K
CEO Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Sharon Mates Kyle W. Gano
Ratings
TAK ZTS HLN TEVA ITCI NBIX
Quant Rating Score 3 3 3 2 1 3
Quant Rating Neutral Neutral Neutral Sell Strong Sell Neutral
Trading
TAK ZTS HLN TEVA ITCI NBIX
Last Close $14.43 $148.6 $9.6 $16.06 $131.87 $132.02
High 52 $15.46 $196.48 $11.41 $22.77 $131.91 $153.29
Low 52 $12.89 $144.45 $8.84 $12.82 $71.19 $87.59
Price vs. 52 Week High -6.66 % -24.37 % -15.86 % -29.47 % -0.03 % -13.88 %
Price vs. 52 Week Low 11.95 % 2.87 % 8.6 % 25.27 % 85.24 % 50.72 %
Total Return
TAK ZTS HLN TEVA ITCI NBIX
1 Month Return -2.3 % -5.45 % -7.78 % -5.25 % 0 % 4.32 %
3 Month Return -1.9 % -0.05 % -6.07 % 17.66 % 0 % 30.22 %
6 Month Return 11.69 % -10.42 % 3.9 % -26.73 % 4.49 % -7.85 %
9 Month Return 0.7 % -23.12 % -4.86 % -10.53 % 68.33 % 11.87 %
YTD Return 8.99 % -8.8 % 0.63 % -27.13 % 57.89 % -3.28 %
1 Year Return 8.01 % -16.79 % 7.74 % -4.46 % 76.16 % -9.38 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TAK ZTS HLN TEVA ITCI NBIX
Dividend Yield Percentage (TTM) 4.52 % 1.23 % 0.01 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 1.65 % 2 % - 2.53 % -227.26 % 14.06 %
Dividend Per Share (TTM) 196 % 1.86 % 0.05 % - - -
Payout Ratio (TTM) 280.28 % 32.25 % - - - -
Growth
TAK ZTS HLN TEVA ITCI NBIX
Asset Growth 8.25 % -9.55 % 87.69 %
Gross Profit Growth 1.76 % 5.47 % 44.88 %
Revenue Growth 5.87 % 4.4 % 46.62 %
Revenue 3 Year 33.13 % 1.52 % 556.51 %
Revenue 5 Year 103.83 % -5.5 % 600974.32 %
Revenue 10 Year 152.69 % -38.45 % 32663.23 %
EBIT Growth -64.98 % -169.63 % 26.77 %
Net Income Growth -54.56 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share -61.74 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share 32.36 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share 35.42 % -140.46 % 32.41 %
Operating Income Growth -56.36 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) -26.69 % -8.85 % 41.08 %
Operating 3 Year CFG -29.25 % 52.26 % 77.79 %
Operating 5 Year CFG 118.64 % 123.59 % 69.4 %
Operating 10 Year CFG 384.17 % -81.66 % 10.87 %
EPS Growth -54.92 % -190 % 50.68 %
EPS Diluted Growth -54.86 % -190 % 50.68 %
Book Value Per Share 13.54 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share 40.38 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share 41.33 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share 195.14 % -82.6 % 164.65 %
Dividend Per Share Growth 1.95 % - -
Dividend 3 Year Growth Per Share 1.19 % - -
Dividend 5 Year Growth Per Share 101.42 % -100 % -
Dividend 10 Year Growth Per Share 102.58 % -100 % -
Debt Growth 10.53 % -10.29 % 0.25 %
Free Cash Flow Growth -31.4 % -11.05 % 40.95 %
Updated On 31 Mar 2024 31 Dec 2024 31 Dec 2024
Profitability
TAK ZTS HLN TEVA ITCI NBIX
Gross Profit Margin TTM 54.7 % 70.2 % 61.52 % 49.17 % 91.63 % 98.25 %
Return on Assets TTM 0.76 % 17.86 % 4.2 % -3.35 % -5.46 % 8.29 %
Return on Equity TTM 1.48 % 51.32 % 8.73 % -21.38 % -7.4 % 11.81 %
Return on Capital Employed TTM 3.75 % 32.08 % 7.74 % 1.59 % -10.05 % 15.71 %
Net Income Per EBT TTM 61.12 % 78.79 % 75.5 % 246.36 % 100.64 % 65.59 %
EBT Per Ebit TTM 40.08 % 92.99 % 86.58 % -120.28 % 63.57 % 93.75 %
EBIT Per Revenue TTM 9.62 % 37.01 % 19.64 % 2.61 % -17.15 % 20.61 %
Cash Flow To Debt Ratio TTM 21.32 % 43.63 % - 7.47 % -430.93 % 118.41 %
Receivables Turnover TTM 6.32 6.82 5.9 4.91 4.09 4.68
Payables Turnover TTM 4.36 6.51 2.19 3.69 2.18 -
Inventory Turnover TTM 1.7 1.16 3.63 2.6 2.17 0.71
Fixed Asset Turnover TTM 232.78 % 253.65 % 584.75 % 332.7 % 4569.25 % 409.47 %
Asset Turnover TTM 32.15 % 65.87 % 32.73 % 43.25 % 49.79 % 65.42 %
Operating Cash Flow Per Share TTM 608.55 6.58 - 1.11 -0.71 5.31
Free Cash Flow Per Share TTM 443.26 5.1 - 0.67 -0.71 4.94
Cash Per Share TTM 24349.44 % 384.5 % 24.05 % 149.12 % 970.67 % 946.34 %
Operating Cash Flow Sales Ratio TTM 21.01 % 31.71 % - 7.62 % -10.75 % 21.96 %
Free Cash Flow Operating Cash Flow Ratio TTM 72.84 % 77.45 % - 60.43 % 100.44 % 92.89 %
Cash Flow Coverage Ratios TTM 21.32 % 43.63 % - 7.47 % -430.93 % 118.41 %
Price To Free Cash Flows Ratio TTM 9.74 29.58 - 24.3 -191.12 26.97
Price To Operating Cash Flows Ratio TTM 7.13 23.03 - 14.57 -185.85 25.23
Price Cash Flow Ratio TTM 7.13 23.03 - 14.57 -185.85 25.23
Income Statement (TTM)
TAK ZTS HLN TEVA ITCI NBIX
Revenue $4263.76B $9.26B $11.23B $16.54B $0.68B $2.36B
Gross Profit $2832.26B $6.54B $6.95B $8.06B $0.62B $2.32B
Gross Profit Ratio 66.43% 70.62% 61.85% 48.74% 91.63% 98.56%
EBITDA $874.6B $3.87B $2.51B $0.72B $-0.12B $0.64B
Net Income $144.07B $2.49B $1.44B $-1.64B $-0.07B $0.34B
EPS Diluted 45.58 5.47 0.32 -1.45 -0.72 3.29
Balance Sheet (MRQ)
TAK ZTS HLN TEVA ITCI NBIX
Long Term Debt $5029.93B $5.39B $8.54B $16.3B $0.01B $0B
Total Liabilities $7834.79B $9.47B $18.09B $33.61B $0.22B $1.13B
Total Equity $7274.01B $4.77B $16.22B $5.72B $1.15B $2.59B
Total Investments $445.7B $0B $0.08B $0B $0.69B $1.71B
Total Debt $4843.75B $6.74B $10.1B $18.08B $0.02B $0.46B
Total Assets $15108.79B $14.24B $34.32B $39.33B $1.37B $3.72B
Cash Flow Statement (TTM)
TAK ZTS HLN TEVA ITCI NBIX
Net Income $144.07B $2.5B $1.44B $-1.96B $-0.07B $0.34B
Inventory $-115.74B $-0.04B $0.22B $0.17B $-0.01B $-0.02B
Dividends Paid $-287.19B $-0.79B $-0.57B $0B $0B $0B
Operating Cash Flow $716.34B $2.95B $2.3B $1.25B $-0.07B $0.6B
Capital Expenditure $-480.73B $-0.66B $-0.25B $-0.5B $-0B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.53
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.21
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 8.63
ALVOW Alvotech 1.65
AMPH Amphastar Pharmaceuticals, Inc. 20.62
AMRX Amneal Pharmaceuticals, Inc. 7.97
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 66.3
APUS Apimeds Pharmaceuticals US, Inc 1.77
AQST Aquestive Therapeutics, Inc. 4.2
ASRT Assertio Holdings, Inc. 0.673
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 10.83
ETFs With Exposure to TAK
Ticker ETF Name Weight Percentage Price
VEU Vanguard FTSE All-World ex-US Index Fund 0 67.17
FVD First Trust Value Line Dividend Index Fund 0.42 45.13
CVY Invesco Zacks Multi-Asset Income ETF 0.434 26.09
GCOW Pacer Global Cash Cows Dividend ETF 0.74 38.19
AFTY Pacer CSOP FTSE China A50 ETF 0.27 16.2826
AGGY WisdomTree Yield Enhanced U.S. Aggregate Bond Fund 0.04 43.28
FPXI First Trust International Equity Opportunities ETF 2.11 55.8817
ICOW Pacer Developed Markets International Cash Cows 100 ETF 1.77 33.92
PPH VanEck Pharmaceutical ETF 2.82 86.25
VETS Pacer Military Times Best Employers ETF 0.18 38.62
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.37 33.28
PTIN Pacer Trendpilot International ETF 0.18 28.645
VALT ETFMG Sit Ultra Short ETF 0.77 48.52
SLT Pacer Salt High truBeta US Market ETF 0.18 39.22
LSLT Pacer Salt Low truBeta US Market ETF 0.18 32
AVDE Avantis International Equity ETF 0.06 73.64
GERM ETFMG Treatments, Testing and Advancements ETF 0.89 19.1577
VIRS Pacer BioThreat Strategy ETF 0.18 40.025
FVL First Trust Value Line 100 Exchange-Traded Fund 0.42 23.1559
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.73 1.75
RTL The Necessity Retail REIT, Inc. 0.27 7.61
BAD B.A.D. ETF 1.51 11.91
AVSD Avantis Responsible International Equity ETF 0.06 66.97
DFIC Dimensional International Core Equity 2 ETF 0.00107651 30.89
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0 41.72
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.00088197 29.48
TRPL Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF 0.18 41.14
OZEM Roundhill GLP-1 & Weight Loss ETF 1.92 25.825
CGCV Capital Group Conservative Equi 0.1 28.96
ENDW Cambria Endowment Style ETF 0 28.59
Unlock